ARTICLE | Clinical News
Betafectin: Began a Phase III trial in 1200 patients to assess safety and efficacy at two doses. The primary end point is reduced percentages of serious infecti
February 27, 1995 8:00 AM UTC
Alpha-Beta Technology Inc. (ABTI), Worcester, Mass. Product: Betafectin, PGG-glucan complex carbohydrate Indication: Prevent infection in gastrointestinal surgery Status: Began a Phase III trial in 12...